Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Regulus Therapeutics Inc (F: 7RG1)

 
7RG1 Technical Analysis
5
As on 28th Jun 2022 7RG1 STOCK Price closed @ 0.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.80 & Strong Sell for SHORT-TERM with Stoploss of 1.23 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

7RG1STOCK Price

Open 0.15 Change Price %
High 0.15 1 Day -0.07 -31.82
Low 0.15 1 Week -0.07 -31.82
Close 0.15 1 Month -0.02 -11.76
Volume 9090 1 Year -0.78 -83.87
52 Week High 1.61 | 52 Week Low 0.12
 
F Germany Most Active Stocks
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
TOE 0.02 0.00%
 
F Germany Top Gainers Stocks
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
8S3B 1.73 620.83%
8S3B 1.73 620.83%
SY7P 0.07 600.00%
P9F1 1.75 326.83%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
AETG 0.25 -91.61%
AETG 0.25 -91.61%
 
 
7RG1
Daily Charts		 7RG1
Intraday Charts		 Whats New @
Bazaartrend		 7RG1
Free Analysis
 
7RG1 Important Levels Intraday
RESISTANCE0.15
RESISTANCE0.15
RESISTANCE0.15
RESISTANCE0.15
RESISTANCE0.15
RESISTANCE0.15
RESISTANCE0.15
RESISTANCE0.15
 
7RG1 Forecast May 2024
Share
4th UP Forecast1.75
3rd UP Forecast1.24
2nd UP Forecast0.92
1st UP Forecast0.6
1st DOWN Forecast-0.3
2nd DOWN Forecast-0.62
3rd DOWN Forecast-0.94
4th DOWN Forecast-1.45
 
7RG1 Weekly Forecast
4th UP Forecast1.11
3rd UP Forecast0.80
2nd UP Forecast0.61
1st UP Forecast0.42
1st DOWN Forecast-0.12
2nd DOWN Forecast-0.31
3rd DOWN Forecast-0.50
4th DOWN Forecast-0.81
 
7RG1 Forecast2024
4th UP Forecast3.33
3rd UP Forecast2.31
2nd UP Forecast1.68
1st UP Forecast1.05
1st DOWN Forecast-0.75
2nd DOWN Forecast-1.38
3rd DOWN Forecast-2.01
4th DOWN Forecast-3.03
 
 
7RG1 Other Details
Segment EQ
Market Capital 39311516.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
7RG1 Address
7RG1
 
7RG1 Latest News
 
Your Comments and Response on Regulus Therapeutics Inc
 
7RG1 Business Profile
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS4326, an anti-miR targeting miR-17, which is in Phase 1 development for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products, which include RGLS5579 glioblastoma multiforme program; and Hepatitis B virus, non-alcoholic steatohepatitis, and cell therapies programs. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California. Address: 4224 Campus Point Court, San Diego, CA, United States, 92121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service